Trial record 1 of 2 for:
vogenx
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05721729 |
Recruitment Status :
Active, not recruiting
First Posted : February 10, 2023
Last Update Posted : March 20, 2024
|
Sponsor:
Vogenx, Inc.
Information provided by (Responsible Party):
Vogenx, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | May 2024 |
Estimated Study Completion Date : | August 2024 |